Indutrade's Record Backlog Comes With a Longer Wait — and a Quiet Hydrogen Reversal

A 15.3% EBITA margin and 13 deals in nine months hide a UK turnaround that just slipped again and an order book that converts later than it used to

INDT.ST · Earnings Call · 2026-10-23

The clean quarter, and the asterisk attached to it

On the face of it, Indutrade delivered the kind of quarter that makes a serial acquirer look easy: order intake up 6% organically with all five business areas improving, organic sales up 5%, total net sales up 13% as acquisitions added 8% and currency a clean zero, EBITA up 19% and the margin climbing from 14.6% to 15.3%. Cash flow rose 20% to SEK 1.2 billion and earnings per share were up 19%. Book-to-bill landed at 101% in a quarter that is seasonally the weakest of the year, and the order backlog sits 11% above last year. Nothing here needs defending. The defence comes unprompted anyway, one page in. Bo Annvik flags that “the order book increasingly consists of longer lead time orders, reflecting continued strong energy sector demand driven by AI and data center investments” — Bo Annvik, CEO · 2026-10-23. That is the first time in this cycle the company has volunteered the mix shift as a caveat rather than a boast. The data center investments flowing through Nordic energy and flow-equipment customers are real, but the revenue from them arrives on a schedule the company does not control. Analysts went straight at it. Max Bacco asked whether the total book still has a healthy blend of short, medium and long paper; Annvik insisted yes — “It's a good mix, and it's absolutely not so that all of the order book is sort of long lead times” — Bo Annvik, CEO · 2026-10-23. But when Ope Otaniyi pressed on timing of conversion across the group, the answer changed register:

There is an order book with a slightly larger content of orders which will be delivered, not Q4 or Q1, but a bit later. It is absolutely manageable and it will not impact our, I would say, organic growth drastically in any way going forward. I think it is prudent for us to mention this so that you are aware of this.
Bo Annvik, CEO · 2026-10-23

"Prudent for us to mention" is doing a lot of work in that sentence. A backlog that is deeper but slower is a different asset than a backlog that is deeper and imminent — it protects the out-year and starves the near-year.

Three quarters of "longer lead times," now with a hedge

The theme itself is not new. In April, Annvik dismissed the question outright: “that's a usual sort of lead time of minimum 6 months, I would say, to more 12 months and beyond. So that's -- but that's a normal situation.” — Bo Annvik, CEO · 2026-04-24 By the July call he conceded that part of the book carried longer lead times in Life Science and energy, with deliveries landing in Q3 and Q4. Now, in October, the same theme has been reclassified from "normal" to "prudent to mention." That is a trajectory worth watching — it is what a demand story looks like when it starts becoming a scheduling story. The market-level tape has already been repricing long lead time items as a positive over the trailing year; Indutrade is telling you the same phrase now carries a deferral cost. None of which undermines the demand read. Construction showed +3%, a notable sequential improvement, but Annvik was careful not to over-claim: “it is a bit of a longer ride before we see really strong uptake” — Bo Annvik, CEO · 2026-10-23. Infrastructure is moving; construction is still soft. Life Science momentum he called roughly flat quarter-on-quarter — “I would say that the momentum is equally strong Q3 as Q2” — Bo Annvik, CEO · 2026-10-23 — with the driver rotating back from medtech toward pharma and single-use, the reverse of the H1 pattern.

The hydrogen retreat nobody put in the headline

The awkward passage of the call sits inside the Technology & Systems Solutions answer. Asked about the segment's persistent margin drag, Annvik described the two troubled UK businesses as “a transformation from they went into the hydrogen business, and now they're transforming back into HVAC and other areas and reestablishing customer relationships” — Bo Annvik, CEO · 2026-10-23. That is a strategic admission dressed as an operational one: an excursion into hydrogen that did not work, a customer base that has to be re-won, and a management team starting over. This is now the fourth consecutive call in which the same two companies are the explanation. In July the hope was explicit — “I really hope that towards at least quarter four, we will see first signs of financial benefit from this transformation” — Bo Annvik, Chief Executive Officer · 2026-07-16. In October that goalpost moved: “it won't be solved in Q4, but I think better and better small steps” — Bo Annvik, CEO · 2026-10-23. Sequentially better, yes; fixed, no. Note also that Systems Solutions is the single highest-ranked keyword in Indutrade's own Q3 vocabulary — the company's most-talked-about phrase is its weakest business area, and it is a label shared with Nordic peers like Lifco, which makes it sector boilerplate rather than a differentiator. The real signal is beneath the label: a failed adjacency and a recovery that keeps sliding right. A second, quieter margin story sits in Process, Energy & Water, where a higher share of project deliveries diluted gross margin even as volumes grew. Annvik's framing is that project-heavy growth is inherently lower-margin than the day-to-day consumable business — filters, seals, valves — and that he expects sequential leverage improvement into Q4. That is a plausible read, but it means the group's margin mix now depends on how much of the energy order book converts as project work versus aftermarket.

Poland, fire protection, and the compounding engine

What is unambiguously working is capital deployment. Thirteen acquisitions year to date carrying SEK 2.1 billion of annual turnover, with the acquired EBITA hitting a record SEK 112 million in the quarter at an 18.3% margin — accretive to the group's 15.3%, and struck before transaction costs. Return on capital employed has moved from 18% to 19% against a 20% target, net debt to EBITDA sits at 1.6x and net debt to equity at 50%. The pipeline is described as strong and the deal sourcing increasingly internal. The geographic tilt is the thing to note. Efforts in Poland are being built as a deliberate platform, following the Northern Italy template, with Euromed and Sinmed added post-quarter; Polish GDP growth, EU funding and a deep bench of family-owned industrial businesses are the stated logic. Schraner, meanwhile, is the first Infrastructure & Construction deal in two years — a non-cyclical operator in the German fire protection systems market. That is a useful hedge against the cyclicality management has explicitly said it wants to avoid in that segment. Worth flagging for governance watchers: this record pace is being run with an interim CFO, Jan Öhman, in the seat after Patrik Johnson's departure.

Where the tape disagrees with the story

Here is the tension worth carrying forward. Indutrade's incremental growth narrative rests substantially on energy and data-center-linked demand — fueled by data center buildup in the Nordics, valves for power generation in the US, gas turbines with very long order books. Yet the market's own read on that cluster has soured. AI data centers ranks among the strongest themes on a trailing-year basis across 41 advancing tickers, but over the last 90 days it sits among the biggest decliners, with roughly 48 of 54 constituents negative. Even the company's own framing has shifted: data centers was Indutrade's number-one keyword two quarters ago as a demand driver; this quarter it appears only as an explanation for why the backlog is slow. A theme that migrates from "what is driving us" to "why the timing is different" is a theme whose narrative value is depreciating. So the honest verdict: this was a genuinely strong quarter on demand, margin and cash, and the acquisition engine is running hotter than it has in years. The risk is not demand. It is sequencing — a backlog converting later, project mix diluting gross margin, and a UK turnaround that has now missed its own stated checkpoints twice. Indutrade rarely gives you a reason to worry about the top line; it is quietly asking you to pay attention to the calendar instead.